Hims & Hers Health is trading at €25.22 (-3.81%) amid broad risk-off pressure.
- Geopolitical tensions pushed oil higher and kept Treasury yields near multi-decade highs, weighing on equities; healthcare was also down 1.49% in the provided sector context.
- No clear company-specific catalyst was identified. The company announced Jon Franklin as chief accounting officer on October 7, but the appointment does not directly explain the decline.